MAPT and tauopathy: In a double-tauopathy mouse model (DM-Tau-tg; P301S, K257T), 0.5 μg IN-NAP daily for ~5 months improved Morris water maze performance to that of controls, increased levels of soluble tau, and decreased neurotoxic hyperphosphorylated tau [106,107].